Stemmatters, a biotechnology company located in Avepark – the Science and Technology Park of Guimarães, will be participating in the BIO International Convention 2025, the world’s largest biotechnology event, taking place in Boston from June 16 to 19.
With a focus on advanced therapies, Stemmatters aims to strengthen its position in the sector and seek new strategic international partnerships during the event. The Guimarães-based company offers integrated solutions ranging from early-stage product and process development to cGMP manufacturing, and is recognized as an excellent partner in the field of cell therapy.
Stemmatters’ CEO, Rui Sousa, will be present at the convention with the goal of establishing contacts with companies, research centers, and investors interested in collaborating on the development of new therapeutic solutions. “We are ready to discuss how Stemmatters can support innovative projects in this rapidly growing field,” the company emphasizes, inviting attendees to schedule meetings via the BIO Partnering App or by email.
Stemmatters’ participation in this international event reinforces Avepark’s commitment to promoting innovation and scientific research of excellence with a global impact, based in Guimarães.
